Join to View Full Profile
1700 S Potomac StAurora, CO 80012
Phone+1 303-418-7600
Fax+1 303-750-3137
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicholas DiBella, MD is an oncologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1969 - 1971- Fitzsimons Army Medical CenterResidency, Internal Medicine, 1966 - 1969
- Letterman Army Medical CenterInternship, Transitional Year, 1965 - 1966
- Keck School of Medicine of the University of Southern CaliforniaClass of 1965
Certifications & Licensure
- CO State Medical License 1972 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 131 citationsRandomized Phase II study of R-CHOP with or without bortezomib in previously untreated patients with non-germinal center B-cell-like diffuse large B-cell lymphomaJohn P. Leonard, Kathryn S. Kolibaba, James A. Reeves, Anil Tulpule, Ian W. Flinn
Journal of Clinical Oncology. 2017-09-01 - 38 citationsRelation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years.Roger M. Lyons, Billie J. Marek, Carole Paley, Jason Esposito, Katie McNamara
Leukemia Research. 2017-05-01 - 38 citationsComparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registryRoger M. Lyons, Billie J. Marek, Carole Paley, Jason Esposito, Lawrence E. Garbo
Leukemia Research. 2014-02-01
Press Mentions
- Decades in Oncology Bring Focus to the FieldNovember 9th, 2017
